Journey of B Cell Dysregulation in Rheumatoid Arthritis: Insights from Immunogenomics
This article focused on abberant B cell activation and immunogenomics aspects of B cells in rheumatoid arthritis. Precise identification of abberant BCR signalling pathways, abberant genetic variats and extensive abnormalities in DNA can provide detailed insights to direct structural and therapeutic interventions against autoimmune and hypersensitive disorders.
Authors
- Kabeer Haneef
- Aftab Ahmed Khand
- Muhammad Saleem Iqbal Khan (ORCID: https://orcid.org/0000-0002-0503-2947)
- Muhammad Umer Asghar (ORCID: https://orcid.org/0000-0003-2572-3179)
- Sajid Muhammad
Institutions
- University of Sindh (PK)
- National Institute for Biotechnology and Genetic Engineering (PK)
- Pakistan Institute of Engineering and Applied Sciences (PK)
- University of Massachusetts Chan Medical School (US)
- Chinese Institute for Brain Research (CN)
- Zhejiang University (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Immunological Investigations
- Published
- 2025-11-15
- DOI
- https://doi.org/10.1080/08820139.2025.2587077
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00